Acquired resistance in cancer: towards targeted therapeutic strategies - Nature Reviews Cancer Acquired therapeutic resistance is a key contributor to cancer treatment failure, requiring new approaches to address its complex mechanisms. In this Roadmap, Soragni, Knudsen and colleagues discuss…

Acquired resistance in cancer: towards targeted therapeutic strategies. #CancerResistance #TargetedTherapeutics @natrevcancer.nature.com‬
www.nature.com/articles/s41...

Chicago did not disappoint! Members of the Bonum team had a fantastic time at the #AACR25 Annual Meeting connecting with peers, partners, and pioneers in cancer research.

Thanks to @theaacr.bsky.social for bringing the global oncology community together in the Windy City.

#TargetedTherapeutics

IGF2BP1 promotes multiple myeloma with chromosome 1q gain via increasing CDC5L expression in an m6A-dependent manner

Scientists from @fudan-university.bsky.social identify a novel IGF2BP1-CDC5L axis and provide new insights into developing #TargetedTherapeutics for #MultipleMyeloma (MM) patients with chromosome 1q gain (1q+). #medsky

#OpenAccess: buff.ly/1oTMalL